Search Results

His work carries direct translational relevance to diabetes and obesity therapeutics. opportunities for scientists and biotech leaders working across pharmacology, translational research, and therapeutic

He is also an Associate Leader of the Experimental Therapeutics and Metabolism Program and the Director

clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics

Sam Hoare Pharmechanics GPCR signaling & biased agonism expert regularly consulted by top pharma companies

Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery

She has advanced the use of computational methods to meet the challenges of designing therapeutics with

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics

His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics

orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic

Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

His research focuses on developing computational pipelines for rational ligand design targeting therapeutically

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic

protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic

receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic

list Strategic Partner(s) Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche About Inês Pinheiro PharmD

neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic

understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic

GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic

Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic

Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State

Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished